COLLEGIUM PHARMACEUTICAL, INC - COLL
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 03, 2026 | EVP & General Counsel | F | D | 8,840.0 | 35.72 | 315,764.8 | 68,231.0 | View | |
| Mar 20, 2026 | EVP & General Counsel | S | D | 13,976.0 | 34.9241 | 488,099.22 | 77,071.0 | View | |
| Mar 11, 2026 | EVP & General Counsel | S | D | 6,224.0 | 36.65 | 228,109.6 | 91,047.0 | View | |
| Mar 05, 2026 | EVP & Chief Commercial Officer | S | D | 3,559.0 | 40.9889 | 145,879.5 | 71,770.0 | View | |
| Mar 05, 2026 | EVP & Chief Commercial Officer | S | D | 46,417.0 | 40.3636 | 1,873,557.22 | 75,329.0 | View | |
| Feb 12, 2026 | President and CEO | F | D | 11,296.0 | 46.75 | 528,088.0 | 197,864.0 | View | |
| Feb 12, 2026 | President and CEO | A | A | 32,531.0 | 0.0 | 0.0 | 209,160.0 | View | |
| Feb 12, 2026 | President and CEO | A | A | 79,264.0 | 0.0 | 0.0 | 176,629.0 | View | |
| Feb 12, 2026 | EVP & Chief Financial Officer | F | D | 26,679.0 | 46.75 | 1,247,243.25 | 147,282.0 | View | |
| Feb 12, 2026 | EVP & Chief Financial Officer | F | D | 11,861.0 | 46.75 | 554,501.75 | 173,961.0 | View | |
| Feb 12, 2026 | EVP & Chief Financial Officer | A | A | 32,734.0 | 0.0 | 0.0 | 185,822.0 | View | |
| Feb 12, 2026 | EVP & Chief Financial Officer | A | A | 26,421.0 | 0.0 | 0.0 | 153,088.0 | View | |
| Feb 12, 2026 | EVP & General Counsel | F | D | 2,781.0 | 46.75 | 130,011.75 | 97,271.0 | View | |
| Feb 12, 2026 | EVP & General Counsel | A | A | 9,005.0 | 0.0 | 0.0 | 100,052.0 | View | |
| Feb 12, 2026 | EVP & General Counsel | A | A | 22,194.0 | 0.0 | 0.0 | 91,047.0 | View | |
| Feb 12, 2026 | EVP & Chief Commercial Officer | F | D | 21,615.0 | 46.75 | 1,010,501.25 | 121,746.0 | View | |
| Feb 12, 2026 | EVP & Chief Commercial Officer | F | D | 9,977.0 | 46.75 | 466,424.75 | 143,361.0 | View | |
| Feb 12, 2026 | EVP & Chief Commercial Officer | A | A | 30,702.0 | 0.0 | 0.0 | 153,338.0 | View | |
| Feb 12, 2026 | EVP & Chief Commercial Officer | A | A | 19,023.0 | 0.0 | 0.0 | 122,636.0 | View | |
| Feb 12, 2026 | EVP and Chief Medical Officer | F | D | 11,538.0 | 46.75 | 539,401.5 | 90,651.0 | View | |
| Feb 12, 2026 | EVP and Chief Medical Officer | F | D | 5,897.0 | 46.75 | 275,684.75 | 102,189.0 | View | |
| Feb 12, 2026 | EVP and Chief Medical Officer | A | A | 22,774.0 | 0.0 | 0.0 | 108,086.0 | View | |
| Feb 12, 2026 | EVP and Chief Medical Officer | A | A | 14,268.0 | 0.0 | 0.0 | 85,312.0 | View | |
| Dec 10, 2025 | EVP & Chief Commercial Officer | M | D | 17,600.0 | 0.0 | 0.0 | 0.0 | View | |
| Dec 10, 2025 | EVP & Chief Commercial Officer | S | D | 6,475.0 | 48.6617 | 315,084.51 | 103,613.0 | View | |
| Dec 10, 2025 | EVP & Chief Commercial Officer | S | D | 11,125.0 | 47.8895 | 532,770.69 | 110,088.0 | View | |
| Dec 10, 2025 | EVP & Chief Commercial Officer | M | A | 17,600.0 | 15.9 | 279,840.0 | 121,213.0 | View | |
| Dec 09, 2025 | — | S | D | 3,650.0 | 47.0338 | 171,673.37 | 52,629.0 | View | |
| Nov 14, 2025 | President and CEO | F | D | 8,983.0 | 47.35 | 425,345.05 | 96,989.0 | View | |
| Nov 14, 2025 | — | M | D | 19,853.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 14, 2025 | — | M | D | 15,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 14, 2025 | — | S | D | 34,853.0 | 47.2136 | 1,645,535.6 | 64,634.0 | View | |
| Nov 14, 2025 | — | M | A | 19,853.0 | 9.33 | 185,228.49 | 99,487.0 | View | |
| Nov 14, 2025 | — | M | A | 15,000.0 | 16.49 | 247,350.0 | 79,634.0 | View | |
| Nov 07, 2025 | EVP & Chief Financial Officer | S | D | 4,858.0 | 41.2756 | 200,516.86 | 126,667.0 | View | |
| Nov 07, 2025 | EVP & Chief Financial Officer | S | D | 25,142.0 | 40.3801 | 1,015,236.47 | 131,525.0 | View |